Get a quick, expert overview of the key issues surrounding best practices and current consensus on major depressive disorder (MDD). This concise resource by Drs. Roger S. McIntyre, Carola Rong, Mehala Subramaniapillai, and Yena Lee consolidates today’s available information on this complex topic into one convenient resource, making it an ideal, easy-to-digest reference for both psychiatrists and primary care physicians. Covers genetics and epigenetics, brain structural abnormalities, cognition, neuroendocrine alterations, and inflammatory abnormalities as they relate to MDD. Contains chapters on psychiatric comorbidity, pharmacological treatments, neuromodulatory treatments, lifestyle interventions, internet-based/technology-based interventions, and glutamate alterations.
|Author||: American Psychiatric Association|
|Publisher||: American Psychiatric Pub|
|Release Date||: 2013-05-22|
|ISBN 10||: 0890425574|
|Pages||: 991 pages|
This new edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5®), used by clinicians and researchers to diagnose and classify mental disorders, is the product of more than 10 years of effort by hundreds of international experts in all aspects of mental health. Their dedication and hard work have yielded an authoritative volume that defines and classifies mental disorders in order to improve diagnoses, treatment, and research. The criteria are concise and explicit, intended to facilitate an objective assessment of symptom presentations in a variety of clinical settings -- inpatient, outpatient, partial hospital, consultation-liaison, clinical, private practice, and primary care. New features and enhancements make DSM-5® easier to use across all settings: The chapter organization reflects a lifespan approach, with disorders typically diagnosed in childhood (such as neurodevelopmental disorders) at the beginning of the manual, and those more typical of older adults (such as neurocognitive disorders) placed at the end. Also included are age-related factors specific to diagnosis. The latest findings in neuroimaging and genetics have been integrated into each disorder along with gender and cultural considerations. The revised organizational structure recognizes symptoms that span multiple diagnostic categories, providing new clinical insight in diagnosis. Specific criteria have been streamlined, consolidated, or clarified to be consistent with clinical practice (including the consolidation of autism disorder, Asperger's syndrome, and pervasive developmental disorder into autism spectrum disorder; the streamlined classification of bipolar and depressive disorders; the restructuring of substance use disorders for consistency and clarity; and the enhanced specificity for major and mild neurocognitive disorders). Dimensional assessments for research and validation of clinical results have been provided. Both ICD-9-CM and ICD-10-CM codes are included for each disorder, and the organizational structure is consistent with the new ICD-11 in development. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, is the most comprehensive, current, and critical resource for clinical practice available to today's mental health clinicians and researchers of all orientations. The information contained in the manual is also valuable to other physicians and health professionals, including psychologists, counselors, nurses, and occupational and rehabilitation therapists, as well as social workers and forensic and legal specialists.
|Release Date||: 2015|
|ISBN 10||: 9789535172406|
|Pages||: 329 pages|
This book focuses on risk factors, clinical and biological characteristics, and treatment options for depression. The aim of this book is to provide readers with an up-to-date understanding of the clinical and neurobiological underpinnings of depression as well as promising treatment for depression. The book is divided into five sections, the first of which examines the clinical heterogeneity of depression. Clinical symptoms, risk factors and treatment options of depression during neurodevelopment and neurodegeneration periods differ from those of depression in adults. Section II highlights bio-psychosocial factors in depression. Major depression cannot be understood without considering the psychosocial environment. Interaction between genetic susceptibility and the psychosocial context affect the occurrence of major depression. Section III focuses on biomarkers of depression. It covers from the overview of biomarkers, focusing on diagnosis, subtyping of depression and treatment response prediction to neuroimaging, genetics, and serum markers in depression. Section IV covers neurobiology and management for treatment-resistant depression. It discusses the etiological issues of treatment-resistant depression including genetic susceptibility, structural and functional MRI markers, neurogenesis, neuroinflammation and neuromodulation treatment for treatment-resistant depression. Section V highlights new perspectives of depression. Neurotrophic hypothesis-driven BDNF-TrkB signalling pathways and downstream of neurotransmitters have attracted attention to new pharmacologic targets. Homeostatic regulation of sleep, its dysregulation in mood disorders, and updated theories between inflammations and depression are discussed. The book will provide a better understanding of clinical and biological features and the management of depression, and will also function as a step onto the path toward the ultimate goal of predicting, preventing and treating depression.
The first book to comprehensively assemble research, clinical, and public policy perspectives on cognitive dysfunction in major depressive disorder.
Major depressive disorder (MDD) is one of the most prevalent mental disorders worldwide, and is estimated to affect 300 million people. Most research defines MDD as a categorical disorder and investigations on clinical, functional, and biological correlates are assessed by established diagnostic instruments. However, given the phenotypic and biological heterogeneity of depression, a re-focus on the clinical phenotype of MDD is required. Bridging psychiatric and psychological traditions Cognitive Dimensions of Major Depressive Disorder, discusses the characteristics of the dimensional approach of MDD. Focusing on the cognitive and emotional processes of depression, this guide offers extended and novel diagnostic and treatment approaches ranging from pharmacological to psychological interventions targeting dimensions of depression. Edited by pioneers in this field, this resource discusses hot topics such as how to define the dimensional approach to depression, the neurobiological underpinnings of cognitive dysfunction in depression, and the impairment of emotional processing deficits in depression. Cognitive Dimensions of Major Depressive Disorder is suitable for students, trainees, clinicians and scientists in the fields of psychology, neuropsychology, psychiatry, cognitive neuroscience, neurology, general practice and also for various other health care professionals.
Part of the Oxford Psychiatry Library (OPL) series, Cognition in Major Depressive Disorder provides a succinct summary of cognitive deficits reported in patients with major depressive disorder (MDD) with a particular focus on aspects of measurement, underlying disease pathophysiology, implications for treatment and prevention. This book also provides readers an opportunity for clinical-based assessment of cognition and recommendations for how cognitive measurement and treatment is positioned in the management of individuals with mood disorders.
Depressive disorders are among the most common conditions in the world and are the leading causes of disability, affecting millions of people. Depression is also a common secondary condition, occurring at increased rates alongside virtually any illness that impacts brain function. Because it is so common, people suffering from depression seek help from a wide variety of clinicians, including: family doctors, pediatricians, gynecologists, psychiatrists, internists, psychologists, social workers and other therapists. In fact, depression is so common that the demand for care far exceeds the availability of psychiatrists, so that most depression is treated by other professionals in other specialty fields. For clinicians without significant experience treating depression, managing the condition can be confusing. This pocket-sized guide was specifically written with this diverse group of clinicians in mind. It provides a concise, practical and current overview of depressive disorders, including making a diagnosis, identifying important medical and psychiatric comorbidities, and describes our current understanding of the epidemiology, genetics and neurobiology of the condition. In addition to these topics, most of this book is focused on a programmatic approach toward managing depression, including subpopulations such as children or women who are pregnant. This book may also be of interest for people experiencing depression and their families to help guide treatment seeking and provide education. Dr. Stephen Strakowski and Dr. Erik Nelson are internationally recognized and trusted experts in the study and treatment of mood disorders whose own extensive clinical experience working with people with depression guides this book.
|Author||: Aamir Saeed Malik,Wajid Mumtaz|
|Publisher||: Academic Press|
|Release Date||: 2019-06-15|
|ISBN 10||: 9780128174203|
|Pages||: 300 pages|
EEG-Based Experiment Design for Major Depressive Disorder: Machine Learning and Psychiatric Diagnosis introduces EEG-based machine learning solutions for the diagnosis and assessment of treatment efficacy for a variety of conditions. With a unique combination of background and practical perspectives for the use of automated EEG methods for mental illness, it details how to design a successful experiment, providing experimental designs for both clinical and behavioral applications. In addition, the book details the pathophysiology of several conditions, including depression, anxiety and epilepsy, along with neural circuits and detailed options for diagnosis. Written to assist in neuroscience experiment design using EEG Provides a step-by-step approach for designing clinical experiments using EEG Includes example datasets for affected individuals and healthy controls Lists inclusion and exclusion criteria to help identify experiment subjects Features appendices detailing subjective tests for screening patients Examines applications for personalized treatment decisions
|Author||: World Health Organization|
|Publisher||: World Health Organization|
|Release Date||: 2009|
|ISBN 10||: 9241547693|
|Pages||: 68 pages|
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
This book provides practical, easy-to-understand information on recognizing, treating, and managing depression.